Work

Effects of nerandomilast, a preferential PDE4B inhibitor, on metabolism of midazolam, a sensitive CYP3A substrate

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa5160

Authors: Shilpa Madari, Yichao Yu, Dilara Jappar, Donald Zoz

Institution: Boehringer Ingelheim (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404096139

Cites:

Cited by: 1

Related to: 10